Science & technology
Science & technology
Novavax creates transformational vaccines that help address some of the world’s most pressing infectious diseases.
- Our pipeline
- Matrix-M™ adjuvant
- Recombinant, protein-based nanoparticle vaccine
- Global vaccine approval/authorization map
Novavax has demonstrated its ability to quickly produce viable vaccine candidates for emerging infectious diseases such as COVID-19.
Who we are
Who we are
We are a biotechnology company committed to help address serious infectious disease globally through the discovery, development, and delivery of innovative vaccines to patients around the world.Build your future with us
Join other passionately curious people who are bringing innovative vaccines to the world
Novavax is committed to accelerating the development of new and promising vaccines by building on years of study and experience.
COMMITTED TO MAKING A DIFFERENCE
We are a biotechnology company committed to help address serious infectious diseases globally through the discovery, development, and delivery of innovative vaccines to patients around the world.
We never rest in our quest to protect the health of people everywhere.
Novavax is here to make a difference. We’re a biotech company focused solely on developing life-saving vaccines to fight infectious diseases.
What sets us apart? Solid science tested by decades of research. Vaccines developed from trusted technology that are both safe and efficacious.
And a global network that will help ensure our vaccines reach everyone who needs them.
How we’re different:
The power & speed of nanoparticle technology
Our vaccine technology combines power and speed with the immunogenicity-enhancing properties of our Matrix-M™ adjuvant to efficiently produce highly immunogenic particles targeting some of the most pressing viral infectious diseases.
Our pipeline is more important than ever
Novavax has demonstrated its ability to produce viable, promising vaccine candidates for emerging infectious diseases.
A commitment to vaccine development
Our scientists are committed to developing vaccine candidates for some of the world’s toughest viral threats by utilizing the power of our innovative recombinant protein-based nanoparticle vaccine platform.
Leaders with deep experience
Our team is composed of experts in drug development who understand science, technology, medicine, and their global context. Our deeply experienced team is unified in the quest to help reduce the burden of infectious disease around the globe.
Our people & culture
Our team is experienced, compassionate, and focused on the future of vaccine development. While growing rapidly, we maintain that small company culture.
Build your future with us
Annual reports, events, and more
Science & Technology
Our pipeline—creating tomorrow's vaccine today
Request for proposal (RFP)
As part of our company’s initiatives, Novavax announces projects that are open for competitive bidding.
At the moment, Novavax is not currently seeking project proposals. Please continue to check this section for updates.